STOCKHOLDERS’ EQUITY |
3 Months Ended |
|---|---|
Mar. 31, 2026 | |
| Equity [Abstract] | |
| STOCKHOLDERS’ EQUITY | STOCKHOLDERS’ EQUITY Common Stock As of March 31, 2026, the Company had 800,000,000 authorized shares of common stock with a par value of $0.0001 per share. At-the-Market Offering Agreements On March 28, 2025, the Company commenced a new at-the-market (“ATM”) offering program pursuant to an ATM agreement, under which the Company may offer and sell shares of its common stock from time to time through the Agents having an aggregate offering price of up to $2.0 billion. For the three months ended March 31, 2026, the Company has not sold any shares of common stock under the ATM. Accumulated Other Comprehensive Loss For the three months ended March 31, 2026, accumulated other comprehensive loss consisted entirely of foreign currency translation adjustments related to our foreign subsidiaries. There were no reclassifications out of accumulated other comprehensive loss for the three months ended March 31, 2026. There was no accumulated other comprehensive loss for the three months ended March 31, 2025. Noncontrolling Interests As of March 31, 2026, noncontrolling interests in stockholders’ equity totaled $16.2 million. This amount represents the non-redeemable portion of third-party ownership interests in consolidated subsidiaries. During the three months ended March 31, 2026, noncontrolling interests in stockholders’ equity increased primarily as a result of the issuance of a noncontrolling interests in MARA France made in connection with the acquisition of Exaion. Changes in noncontrolling interests in stockholders’ equity are presented in the Condensed Consolidated Statements of Equity. Refer to Note 3 – Acquisitions and Strategic Partnerships, for further information.
|